OTC Switch Sponsors Should Study Up On FDA Procedure, FDAer Suggests
This article was originally published in The Tan Sheet
Executive Summary
OTC drug submission sponsors should be up to speed on all of FDA's application procedures when developing a switch program, according to OTC Division Medical Officer Andrea Leonard-Segal, MD